Utah Medical Products (UTMD)
Makes specialty medical devices for labor, neonatal, gynecology, urology, and pressure-monitoring settings.
Something off on this page? Send us feedback.
Makes specialty medical devices used in NICUs, labor and delivery, women's health, outpatient clinics, and physicians' offices, with revenue grouped around gynecology, neonatal care, blood-pressure monitoring, and obstetrics. Acquired product lines remain central to the portfolio.
Builds specialty medical devices for labor and delivery, neonatal intensive care, gynecology, urology, blood-pressure monitoring, women's pelvic health, OEM capabilities, and biopharma applications. The portfolio includes long-running product families such as Filshie, Deltran, Intran Plus, Gesco neonatal devices, and obstetric tools.
Manufacturing is centered in Utah and Ireland, while distribution reaches U.S. and international medical facilities through direct channels, subsidiaries, distributors, and OEM relationships. Acquired product lines from Columbia Medical, Gesco, Abcorp, and Femcare remain important to the current mix.
Runs as a single operating segment under long-tenured leadership. Device-by-device competition is fragmented, OEM work faces lower-cost component manufacturers abroad, and recent customer changes in OEM and China blood-pressure kits shape near-term execution.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $87.5M · Total debt $195.0K · Total assets $124.6M · Shareholders' equity $122.0M
- Revenue
- $8.5M
- Operating income
- $2.7M
- Net income
- $2.7M
Raised for 20 straight years — most recently to $0.31 from $0.305 in Dec 2025. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Sep 17, 2026 | Sep 17 | Oct 5 | $0.31 | upcoming |
| Jun 17, 2026 | Jun 17 | Jul 3 | $0.31 | |
| Mar 17, 2026 | Mar 17 | Apr 3 | $0.31 | |
| Dec 16, 2025 | Dec 16 | Jan 5 | $0.31 | raised from $0.305 |
| Sep 17, 2025 | Sep 17 | Oct 2 | $0.305 | |
| Jun 16, 2025 | Jun 16 | Jul 3 | $0.305 | |
| Mar 14, 2025 | Mar 14 | Apr 3 | $0.305 | |
| Dec 16, 2024 | Dec 16 | Jan 3 | $0.305 | raised from $0.30 |
| Sep 20, 2024 | Sep 20 | Oct 4 | $0.30 |
| Institutions115 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | ≈ 73.15% | 2.33M shares | |
| Insiders3 holders · as of Jul 1, 2026 | 0.68% | 21.6K shares | |
| Otherremainder | ≈ 26.17% | 833.4K shares |
3.18M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Brandes Investment Partners, LPInstitution | 14.92% | 475,158 | 13Fas of Jun 30, 2026 |
T. Rowe Price Investment Management, Inc.Institution | 10.74% | 341,916 | 13Gfiled Feb 14, 2023 ↗ |
BlackRock, Inc.Institution | 6.40% | 203,690 | 13Fas of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 6.24% | 198,817 | 13Fas of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 5.52% | 175,814 | 13Fas of Jun 30, 2026 |
| See all 25 → | |||
13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more
Insider tradesForm 4
No open-market trades in the last 12 months.
- CooperCompanies
Women's health and OB/GYN devices at larger scale
- BD
Vascular access, urology, and advanced monitoring scale
- ICU Medical
Critical-care monitoring and vascular-access disposables
- Teleflex
Vascular access, urology, anesthesia, and OEM devices
- Merit Medical Systems
Hemodynamic monitoring, access devices, and OEM components
- CONMED
Electrosurgery and minimally invasive surgical devices
- Integer
Medtech OEM components and finished-device manufacturing
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Utah Medical Products | $71.79 | +0.04% | $228.1M | 21.8 | — | 6.3 | −14.3% |
| CooperCompanies | $70.21 | +0.67% | $13.60B | 59.1 | 14.7 | 3.2 | +7.9% |
| BD | $189.24 | +0.88% | $51.67B | 56.5 | 14.2 | 2.5 | −9.6% |
| ICU Medical | $171.00 | +0.65% | $4.25B | 143.9 | 19.2 | 2.0 | −0.2% |
| Teleflex | $140.89 | +0.03% | $6.24B | — | 15.3 | 2.4 | −27.0% |
| Merit Medical Systems | $91.35 | +1.33% | $5.38B | 37.2 | 20.6 | 3.4 | +9.5% |
| CONMED | $49.70 | +0.54% | $1.48B | 26.7 | 11.0 | 1.1 | +0.3% |
| Integer | $125.31 | 0.00% | $4.25B | 34.2 | 18.8 | 2.3 | −2.6% |
| Median | 46.9 | 15.3 | 2.4 | −0.2% |